tyrosine has been researched along with neurotensin (8-13) in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cherniakova, IV; Gudasheva, TA; Klodt, PM; Kolik, LG; Konstantinopol'skiĭ, MA; Kudrin, VS | 1 |
Besserer-Offroy, É; Brouillette, RL; Leduc, R; Longpré, JM; Marsault, É; Sarret, P; Sousbie, M; Vivancos, M | 1 |
2 other study(ies) available for tyrosine and neurotensin (8-13)
Article | Year |
---|---|
[Neurotensin NT (8- 13) dipeptide analog dilept increases the pain threshold and decreases the severity of morphine withdrawal syndrome in rats].
Topics: Animals; Dopamine; Frontal Lobe; Hypothalamus; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Neurotensin; Pain; Pain Threshold; Peptide Fragments; Proline; Rats; Serotonin; Severity of Illness Index; Substance Withdrawal Syndrome; Tyrosine | 2013 |
Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13).
Topics: Analgesics, Non-Narcotic; Animals; Binding, Competitive; Blood Pressure; Body Temperature; CHO Cells; Cricetulus; Cyclization; Drug Evaluation, Preclinical; Drug Stability; Male; Molecular Docking Simulation; Neurotensin; Peptide Fragments; Peptides, Cyclic; Rats, Sprague-Dawley; Receptors, Neurotensin; Structure-Activity Relationship; Tyrosine | 2018 |